| AWIIX | CLBAX | AWIIX / CLBAX | |
| Total Expense Ratio | 0.68 | 0.58 | 117% |
| Annual Report Gross Expense Ratio | 0.68 | 0.58 | 117% |
| Fund Existence | 12 years | 24 years | - |
| Gain YTD | -1.831 | 10.621 | -17% |
| Front Load | N/A | 4% | - |
| Min. Initial Investment | 250000 | 250 | 100,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 609M | 269B | 0% |
| Annual Yield % from dividends | 2.03 | 1.70 | 119% |
| Returns for 1 year | -2.79 | 9.19 | -30% |
| Returns for 3 years | 20.45 | 37.64 | 54% |
| Returns for 5 years | 20.98 | 36.41 | 58% |
| Returns for 10 years | 104.47 | 85.38 | 122% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ARLU | 30.67 | 0.11 | +0.36% |
| AllianzIM U.S. Equity Buffer15 UncAprETF | |||
| DSMC | 36.13 | 0.12 | +0.33% |
| Distillate Small/Mid Cash Flow ETF | |||
| NMAI | 12.96 | 0.02 | +0.15% |
| Nuveen Multi-Asset Income Fund | |||
| IHI | 62.73 | 0.09 | +0.14% |
| iShares US Medical Devices ETF | |||
| IYRI | 48.92 | 0.01 | +0.02% |
| NEOS Real Estate High Income ETF | |||